health

Through a partnership, South African doctors shadow UCLA physicians in Los Angeles and then return to their home country to put into practice what they’ve learned.

The new work will continue a study that began in 2013 with a $7 million grant from the National Institute on Drug Abuse.

The funds will support pediatrics faculty who are focused on enhancing quality of life for people with cerebral palsy, autism, and other developmental and behavioral challenges.

Hosea Nelson and Jose Rodriguez have been selected among 22 early career researchers for the awards which provides funding for work advancing human health.

The findings help explain the connection between HDL cholesterol and reduced cancer risk, and suggest that a similar compound may be an effective therapy in humans.

The team performed a staggering 363 kidney transplants in 2017, more than any other transplant center in the United States, according to data.

Forbes ranks UCLA Health No. 43 in the nation among all industries; and Becker’s Healthcare lists it among the 150 Top Places to Work in Healthcare for 2018.

“Our physicians exemplify — every day — UCLA Health’s mission of delivering leading-edge patient care, research and education,” said Johnese Spisso, president of UCLA Health.

The awards, which total nearly $2.3 million, will support work by professors at the UCLA Fielding School of Public Health and the UCLA Graduate School of Education and Information Studies.

A detailed view of its core may lead to the development of targeted drugs.

Some 200 UCLA medical students received their diplomas Friday, June 1, in Dickson Court at the 64th annual Hippocratic Oath Ceremony for the David Geffen School of Medicine at UCLA.

Instructors from the American Heart Association taught more than 700 guests how to perform hands-only lifesaving techniques.

Nearly 30 percent of people in the ongoing trial have survived for at least three years after they enrolled in the study; the average life expectancy for people with glioblastoma is 15 to 17 months.

Understanding colon cancer's ability to change its genes — a process called immunoediting — could help researchers develop new immunotherapies that target those genetic changes, leading to more effective treatments.

The next step is to determine why the numbers are so low and find ways to increase those rates of testing.

The study is the first to establish a link between susceptibility to seizures and the gut microbiota — the 100 trillion or so bacteria and other microbes that reside in the human body’s intestines.

African-American and low-income kids are the most at risk for health problems as the biggest consumers of sweetened beverages, a study by the UCLA Center for Health Policy Research has found.

UCLA researchers designed Chatterbaby, which uses artificial intelligence to help determine if baby is hungry, fussy or in pain.

The research “may reassure some people that despite testing positive on screening tests, their chances of developing Alzheimer’s disease dementia is low,” said UCLA’s Ron Brookmeyer.

Researchers engineered a hydrogel that, when injected into the brain, thickens to create a scaffolding into which blood vessels and neurons can grow.

In a prior study, the same researchers showed that pathologists disagreed about the diagnosis of early-stage invasive melanoma more than 50 percent of the time.

The process analyzes several possible risk scenarios to help doctors more thoroughly assess people who could be candidates for heart transplants.

The study analyzed data from 2009 to 2011 in six U.S. cities; the findings could help shape prevention programs.

Women infected by the virus during pregnancy were 10 times more likely than the general population to give birth to babies with major cardiac problems, researchers found.

The research in marine snails could lead to new treatments to restore memories and alter traumatic ones in people with Alzheimer's disease and those dealing with post-traumatic stress disorder.